Navigation Links
MabVax Therapeutics Initiates Phase II Clinical Trial of Vaccine to Prevent Recurrent Sarcoma
Date:7/22/2010

SAN DIEGO, July 22 /PRNewswire/ -- MabVax Therapeutics Inc., a privately held clinical stage biotechnology company focused on the development of vaccine and antibody based therapies to address the unmet medical need of preventing recurrent cancer, announces that the first patients have been enrolled in a Phase II clinical trial aimed at assessing the efficacy and safety of its vaccine to prevent or delay the recurrence of sarcoma. The clinical trial will enroll 126 metastatic sarcoma patients, 16 years or older in a randomized, multicenter, double-blind Phase II study of a trivalent vaccine specifically developed to target and kill residual circulating cancer cells and micrometastases thought to cause recurrent cancer.  

In the United States (US), there are approximately 13,200 sarcoma cases diagnosed each year, representing less than 1% of all new cancers.  Prognosis remains poor, with more than 5,200 patients in the US dying of disease each year.  As in other malignancies, disease recurrence and metastasis are common in sarcoma.  Despite undergoing potentially curative surgical resection or combination therapy, the majority of these patients with recurrent sarcoma die as a result of further recurrences.  The addition of chemotherapy to surgical resection has not shown to improve outcome in adult patients with sarcoma. Thus, in the majority of cases, the current standard of care following treatment of metastatic disease and the achievement of disease-free status is expectant management.

The vaccine is a trivalent ganglioside vaccine administered with an immunological adjuvant in a series of 10 subcutaneous injections given over an 84-week period.  The vaccine is intended to instruct the patient's immune system to make antibodies against the three ganglioside ant
'/>"/>

SOURCE MabVax Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. MabVax Therapeutics Closes Two Licensing Agreements With Sloan-Kettering Institute for Cancer Research
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
4. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
5. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
8. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
9. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
10. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
11. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Aug. 29, 2014  BC Technical, the nation,s leading ... Medical Imaging, a leader in sales, service and installation ... allows BC Technical to continue to expand their resources ... and CT modalities. "We are committed ... Mark Alvarez , president and CEO of BC Technical. ...
(Date:8/29/2014)... -- Does your doctor know what you,re smoking?  Chances are, ... to the over 112,000 currently registered patients under ... other roughly 20,300+ active physicians listed with the Colorado Dept ... even though a poll in February 2014 showed 51% of ... it. "With marijuana legalization underway, every doctor ...
(Date:8/29/2014)... WASHINGTON , Aug. 29, 2014 Diseases ... a generation ago are returning. Measles was declared ... cases in 2014 as of August 15—the highest incidence ... public health department declared whooping cough a problem ... children are getting sick and dying from these preventable ...
Breaking Medicine Technology:BC Technical Acquires Polaris Medical Imaging 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3
... M.D., president of SPRI,Clinical Trials, will be a featured ... Group Investor Seminar -- Management,s Guide to,Wall Street. The ... Midtown,Loft & Terrace, 267 Fifth Avenue in New York. ... and small and mid-cap life science companies to gain,better ...
... In the news release, "Update on the SEAS Study" issued ... Principal Investigator & Head,of Steering Committee over PR Newswire, we ... information has been added to the,release:, , Satellite coordinates, ... Satellite: AB1 12.5 Deg West Txp: B6 Lower, ...
Cached Medicine Technology:/C O R R E C T I O N -- Prof Terje Pedersen, SEAS Study Principal Investigator & Head of Steering Committee/ 2/C O R R E C T I O N -- Prof Terje Pedersen, SEAS Study Principal Investigator & Head of Steering Committee/ 3
(Date:8/31/2014)... Fe, New Mexico (PRWEB) August 31, 2014 ... a Disability Rights friend-of-the-court brief in support of the ... district court ruling that the New Mexico constitution contains ... No. 33,630, Court of Appeals of the State of ... joined in the brief: ADAPT, the American Association ...
(Date:8/31/2014)... 31, 2014 Kicking blog MichaelHusted.com ... Nelson of Matt Nelson Kicking Academy on his role ... being a National Camp Series (NCS) Associate according to ... "Matt Nelson is another high quality to our NCS ... coaching. He is an outstanding pro prospect kicker, ...
(Date:8/31/2014)... 31, 2014 The severity of menopausal ... specializing in menopause is expert in helping patients ... relief from uncomfortable symptoms with the latest treatment options, ... offer a variety of alternative treatments and products that ... treatment options may fall outside of what can be ...
(Date:8/30/2014)... 2014: A new method to predict the optimal ... presented at ESC Congress today by Dr Benjamin Dahan ... 350 AEDs located in public places for optimal prevention ... Dahan said: "Out of hospital cardiac arrest is a ... between 50 and 100 per 100 000 in the ...
(Date:8/30/2014)... August 31, 2014 According to the latest ... by step holistic system for skin health. It seems that ... been tried by more than 138,000 patients from all over ... Walden, who says that this method will not only eliminate ... skin. , What makes this program unique among other ...
Breaking Medicine News(10 mins):Health News:Not Dead Yet and Six Other National Disability Groups Submit Friend-of-the-Court Brief in New Mexico Assisted Suicide Appeal 2Health News:Not Dead Yet and Six Other National Disability Groups Submit Friend-of-the-Court Brief in New Mexico Assisted Suicide Appeal 3Health News:MichaelHusted.com Features an Interview with Matt Nelson of Matt Nelson Kicking Academy on His Role as a Kicking Coach and on Becoming a National Camp Series Associate 2Health News:MichaelHusted.com Features an Interview with Matt Nelson of Matt Nelson Kicking Academy on His Role as a Kicking Coach and on Becoming a National Camp Series Associate 3Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 2Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 3Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 4Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 5Health News:New method predicts optimal number and location of AEDs 2Health News:Acne No More Review Reveals Unusual Tip to Eliminate Acne Permanently 2
... NEW YORK, Feb. 26 With sensational headlines about multiple ... fact that infertility is a painful reality for many couples ... million Americans struggle with fertility issues, and the number is ... has doubled in size and now exceeds $3 billion. ...
... As the voice of the global clinical ... (ACRO) had the honor of presenting before the ... 2009 in Tokyo. ACRO Chair Derek Winstanly, MBChB, ... ACRO Executive Director Douglas Peddicord, Ph.D. addressed "Representing ...
... number of potential medicines to treat heart disease and ... by the Pharmaceutical Research and Manufacturers of America (PhRMA) ... medicines to treat these diseases currently are being tested ... the U.S. Food and Drug Administration, compared to 146 ...
... Secure Message Capability to Facilitate Instant Collaborative ... Science, Inc. (HSI), a Rockville Innovation Center ... an innovative software service that enables physicians ... a secure environment. PatientCarenet.Org connects community-based ...
... as keys to successLAS VEGAS, Feb. 26 The ... ) (AAOS) is honored to recognize a surgeon who has ... backgrounds to pursue the orthopaedic specialty and who has never ... presented today with the Academy,s Diversity Award at its 2009 ...
... first considered a life in medicine at the ripe old ... and tribulations of a young television doctor named Ben Casey. ... sparked an idea which led to an impressive and successful ... Zuckerman was named President of the American Academy of ...
Cached Medicine News:Health News:A Recession-Resistant Business? Introducing FertilityAuthority.com 2Health News:ACRO Presents at Japan CRO Association Commemorative Symposium 2Health News:Record Number of Innovative New Medicines for Heart Disease and Stroke Now in Development 2Health News:Record Number of Innovative New Medicines for Heart Disease and Stroke Now in Development 3Health News:Human Science, Inc. Launches PatientCarenet.Org 2Health News:Human Science, Inc. Launches PatientCarenet.Org 3Health News:Ramon L. Jimenez, MD: A Diverse Life 2Health News:Ramon L. Jimenez, MD: A Diverse Life 3Health News:Joseph D. Zuckerman, M.D., Elected President of the American Academy of Orthopaedic Surgeons 2Health News:Joseph D. Zuckerman, M.D., Elected President of the American Academy of Orthopaedic Surgeons 3
Now available in 2.75-mm diameters, the S660 small vessel coronary stent expands your treatment options for accurate sizing and precision stenting....
Rapid Exchange Stent Delivery System...
The MULTI-LINK PIXEL Coronary Stent System was designed to address the challenges of small vessel treatment in patients with abrupt or threatened abrupt closure (ATC)....
IVUS console...
Medicine Products: